| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.091 | 0.5 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |